carbachol has been researched along with Alveolitis, Fibrosing in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Namba, Y | 1 |
Togo, S | 1 |
Tulafu, M | 1 |
Kadoya, K | 1 |
Nagahama, KY | 1 |
Taka, H | 1 |
Kaga, N | 1 |
Orimo, A | 1 |
Liu, X | 1 |
Takahashi, K | 1 |
Barrio, J | 1 |
Cortijo, J | 1 |
Milara, J | 1 |
Mata, M | 1 |
Guijarro, R | 1 |
Blasco, P | 1 |
Morcillo, EJ | 1 |
2 other studies available for carbachol and Alveolitis, Fibrosing
Article | Year |
---|---|
Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
Topics: Adrenergic beta-2 Receptor Antagonists; Aged; Carbachol; Dose-Response Relationship, Drug; Drug Ther | 2017 |
In vitro tracheal hyperresponsiveness to muscarinic receptor stimulation by carbachol in a rat model of bleomycin-induced pulmonary fibrosis.
Topics: Animals; Bleomycin; Bronchial Hyperreactivity; Calcium Signaling; Carbachol; Disease Models, Animal; | 2006 |